Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Althea Group.
RELATED STOCKHEAD STORIES
News
ASX Health Stocks: Althea strikes deal in Canada, will make 40pc of all cannabis-infused drinks in the country
News
Market Highlights: Meta surges 14pc, uranium stocks most traded by Aussies, and 5 small caps to watch today
Health & Biotech
ASX Biotech October Winners: Dimerix, Noxopharm and Chimeric dominate as investors hunt next big thing in pharma
Health & Biotech
Weed Week: US House Speaker ousting could boost weed stocks; TGA urged to allow the term ‘medicinal cannabis’
Health & Biotech
ASX Health Stocks: Althea’s cannabis oil approved for reimbursement in Ireland, Imugene begins Phase 1 trial
Health & Biotech
Check Up: Why Goldman Sachs won’t change its ratings on 3 ASX stocks despite Ozempic-driven selloff
Health & Biotech
ASX Health Stocks: Global Health nabs Fujitsu contract, Althea generates $5.3m after property deal
News
In Case You Missed It: Gold sales and big gold hits take the cake
News
Top 10 at 11: Lithium and gold are popular again, but Kazia’s de-listing and falling fast
Health & Biotech
ASX Health Stocks: Althea says its cannabis beverage could generate $5m of sales in Canada
Health & Biotech
ASX Health Stocks: Starpharma jumps 10pc on study results; Mach7 announces $3.7m deal
Health & Biotech
Weed Week: Greens reckon legal cannabis could generate $28 billion over a decade
Health & Biotech
Weed Week: Oregon pardons cannabis convictions and bulk people light up on Turkey Day
Health & Biotech
Weed Week: More US states vote to legalise cannabis and Czech Republic to follow in Germany’s footsteps
Explainers
ASX Cannabis Stocks Guide 2022/23: Here’s everything you need to know
Health & Biotech
ASX Health Stocks: Invion surges 17pc after saying its lead drug can kill anal cancer
News